BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh P, Kumar Sigalapalli D, Sridhar Goud N, Swain B, Kumar Sahoo S, Angeli A, Shaik AB, Madhavi Yaddanapudi V, Supuran CT, Arifuddin M. Ureidosulfocoumarin Derivatives As Selective and Potent Carbonic Anhydrase IX and XII Inhibitors. ChemMedChem 2021;:e202100725. [PMID: 34898017 DOI: 10.1002/cmdc.202100725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Vats L, Siwach K, Angeli A, Bikal P, Bhardwaj JK, Supuran CT, Sharma PK. Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis. Arch Pharm (Weinheim) 2023;356:e2200439. [PMID: 36344431 DOI: 10.1002/ardp.202200439] [Reference Citation Analysis]
2 Obadawo BS, Oyeneyin OE, Olanrewaju AA, Metibemu DS, Emaleku SA, Owolabi TO, Ipinloju N. Predicting the Anticancer Activity of 2-alkoxycarbonylallyl Esters against MDA-MB-231 Breast Cancer - QSAR, Machine Learning and Molecular Docking. Curr Drug Discov Technol 2022;19:e110822207398. [PMID: 35959613 DOI: 10.2174/1570163819666220811094019] [Reference Citation Analysis]
3 Nerella SG, Singh P, Arifuddin M, Supuran CT. Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022. Expert Opin Ther Pat 2022. [PMID: 35616541 DOI: 10.1080/13543776.2022.2083502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]